Series date: 
01/01/2022 - 7:30am to 12/31/2022 - 7:30am

DESCRIPTION
This series is held weekly on Friday, 7:30 - 8:30 a.m.

Consultants, fellows and visiting professors present a 45 minute discussion topic which is intended to be a comprehensive review after which there is a 10-15 minute period for questions.  These "state-of-the-art" lectures are directed at the faculty and fellow level.  

TARGET AUDIENCE
The audience is primarily the physicians in our division, but all members of the division, i.e. nurses, NP/PAs and allied health staff are encouraged to attend.  Other areas/divisions are allowed to attend if they wish.  

LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:

  • Describe how to apply clinical practice updates to improve patient outcomes.

  • Critically review clinical and basic research literature using an evidence-based approach.

  • Debate if specific findings are relevant and applicable to patient care.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Statement(s): 
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies: 
Hatem Amer, M.D. - Grant/Research - Department of Defense and Kaneka Pharma
 
All relevant financial relationships listed for these individuals have been mitigated.

No relevant financial relationship(s) with ineligible companies: 
Iasmina M. Craici, M.D.
Suzanne M. Norby, M.D.
Ladan Zand, M.D.
Melissa L. Hanson
Kathy Hegna Zelinske
Jacqlyn A. Oakland (added 2/9/22)

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010image within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

COURSE DIRECTORS
Hatem Amer, M.D., Suzanne Norby, M.D., Ladan Zand, M.D., Iasmina Craici, M.D.

QUESTIONS?
Contact Kathy Hegna Zelinske at phone 6-1044 OR Jacqlyn Oakland at phone 4-3479

*Required Information for Accreditation is posted in Outlook Calendar Invitation.
Where did the idea for the course originate?: 
Minnesota

Sessions

Session Date
Nephrology Hypertension Journal Club-Recovery From Dialysis-Treated Acute Injury in Patients With Cirrhosis: A Population-Based Study - May 27, 2022 05/27/2022 - 7:30am to 8:30am
Nephrology Hypertension Journal Club -Treatment for Mild Chronic Hypertension during Pregnancy - June 3, 2022 06/03/2022 - 7:30am to 8:30am
Nephrology Hypertension Journal Club - Fracture Risk of Sodium - Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease - June 17, 2022 06/17/2022 - 7:30am to 8:30am
Nephrology Hypertension Journal Club-Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial - June 24, 2022 06/24/2022 - 7:30am to 8:30am
CANCELLED - Nephrology Hypertension Journal Club, July 1, 2022 07/01/2022 - 7:30am to 8:30am
Nephrology Hypertension Journal Club-Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy-June 8, 2022 07/08/2022 - 7:30am to 8:30am
Nephrology Hypertension Journal Club - Restriction of Intravenous Fluid in ICU Patients with Septic Shock - July 15, 2022 07/15/2022 - 7:30am to 8:30am
Nephrology Hypertension Journal Club - Timing of Dialysis Initiation to Reduce Mortality and Cardiovascular in Advanced Chronic Kidney Disease - July 22, 2022 07/22/2022 - 7:30am to 8:30am
Nephrology Hypertension Journal Club - Effectiveness and Safety of Apixaban versus Warfarin in VTE Patients with CKD - July 29, 2022 07/29/2022 - 7:30am to 8:30am
Nephrology Hypertension Journal Club-Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses-August 5, 2022 08/05/2022 - 7:30am to 8:30am

Pages